GlassScriptPhysician profile
Thomas J Bobrowski
NPI 1346229671
$745.05
in general payments reported to CMS, 2019-2025
12 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.88 · 2020: $93.68 · 2022: $131 · 2023: $287 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $172.19 | 2022-2023 | Grafix Pl, Stravix, Grafix Xc |
| Imbed Biosciences INC. | $134.09 | 2023 | |
| Abbvie INC. | $125.00 | 2025 | |
| Grt US Holding, INC. | $94.11 | 2020-2022 | |
| Organogenesis INC. | $78.91 | 2020-2025 | Apligraf |
| Kowa Pharmaceuticals America, INC. | $30.84 | 2022-2023 | Seglentis |
| Amgen INC. | $27.84 | 2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $25.22 | 2019-2020 | |
| Treace Medical Concepts, INC. | $22.07 | 2025 | |
| Orthofix Medical, INC. | $12.17 | 2020 | |
| Zyla Life Sciences, INC. | $11.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bobrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.